475f Cobiprostone Demonstrates Protective Effects Against Non-Steroidal Anti-Inflammatory Drug (NSAID)-Induced Gastrointestinal Injury

G A A b st ra ct s 1.01 (95% CI, 0.83-1.23) for women who used 0.5 to 1.5 standard tablets/week, 1.25 (95% CI, 1.02-1.53) for 2 to 5 tablets/week, 1.71 (95% CI, 1.38-2.13) for 6-14 tablets/week, and 2.11 (95% CI, 1.53-2.91) for >14 tablets/week (P 5 years; P